Tecogen Inc. (TGEN)

3.35
0.02 0.59
NASDAQ
Prev Close 3.33
Open 3.36
Day Low/High 3.32 / 3.36
52 Wk Low/High 2.46 / 6.50
Volume 9.91K
Exchange NASDAQ
Shares Outstanding 24.71B
Market Cap 80.54M
Div & Yield N.A. (N.A)

Latest News

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BSX, RMP, TGEN Downgrades: ESCA, VYGR Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Tecogen Presenting At SAE World Congress

Presenting paper on development of Ultera emissions technology on vehicles

TTcogen Hires Alternatives Project Development Expert To Lead Biofuel CHP Effort

Walter Gray III to join as Director of Business Development

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ENTA, PFIE, SONC Downgrades: AA, ARLP, FRAN, GSM, PAA, SGA Initiations: ANY, CTRE, DNOW, JD, SEMI, TGEN, TIME Read on to get TheStreet Quant Ratings' detailed report:

5 Stocks Under $10 Making Big Moves Higher

5 Stocks Under $10 Making Big Moves Higher

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

4 Stocks Under $10 Making Big Moves

4 Stocks Under $10 Making Big Moves

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Targeted Genetics To Host Conference Call And Webcast Discussion Of Annual Shareholders Meeting On February 18, 2011

Targeted Genetics Corporation (TGEN.PK) announced today that it will webcast its annual shareholder meeting on Friday, February 18, 2011 at noon ET/9:00 a.

Targeted Genetics Corporation Updates Investors On Annual Meeting Matters

Targeted Genetics Corporation (Pink Sheets:TGEN), or the Company, today announced that the Superior Court of the State of Washington issued an order authorizing the Company to set the record date for the Company’s ...

Targeted Genetics Corporation Completes Acquisition Of Biocontrol Limited

Targeted Genetics Corporation (“Targeted Genetics”), (Pink Sheets:TGEN), today announced the completion of the acquisition of Biocontrol Limited (“Biocontrol”).

Targeted Genetics Corporation Updates Investors On Annual Meeting Matters

Targeted Genetics Corporation, (PINKSHEETS:TGEN.PK), or the Company, today announced that the Superior Court of the State of Washington issued an order resetting the record date for the Company’s annual meeting...

Koyote Trading Welcomes Washington State Court Decision On Targeted Genetics’ Annual Meeting

Koyote Trading LLC, ("Koyote" or “the Company”) an institutional investor of Targeted Genetics (“Targeted”) (OTC: TGEN.

Targeted Genetics Corporation Announces Annual Meeting Date

Targeted Genetics Corporation, (Pink Sheets: TGEN), or the Company, today announced that the Company’s next Annual Meeting of shareholders will be held on January 27, 2011, at 11:00 a.

Targeted Genetics Corporation Announces Plan For Next Annual Meeting

Targeted Genetics Corporation, (Pink Sheets:TGEN), or the Company, today announced that it intends to hold the Company’s next Annual Meeting of shareholders in the spring of 2011.

Targeted Genetics’ Partner Celladon Corporation Reports 12 Month Follow Up Data From Phase 2 Clinical Trial Of Patients Treated With MYDICAR®

Targeted Genetics Corporation (Pink Sheets: TGEN.PK) (“Company”) announced that its partner, Celladon Corporation, today presented 12-month data from its Phase 2 CUPID clinical trial of MYDICAR® ...

Targeted Genetics Corporation Reports Fourth Quarter And Full Year 2009 Financial Results

Targeted Genetics Corporation (PINKSHEETS: TGEN) (the “Company”) today announced its financial results for the fourth quarter and full year ended December 31, 2009.

Targeted Genetics’ Partner Celladon Corporation Reports Positive Phase 2 Clinical Trial Data At Heart Failure Association Annual Meeting

Targeted Genetics Corporation (Pink Sheets:TGEN) (“Company”) announced that its partner, Celladon Corporation, presented full data today that show the first Phase II trial with MYDICAR® for the treatment of ...

Targeted Genetics’ Partner, Celladon Corporation, Reports Achievement Of Primary Endpoints In Phase II Clinical Trial Of MYDICAR® For The Treatment Of Advanced Heart Failure

Targeted Genetics Corporation (Pink Sheets:TGEN) (the “Company”) announced today that its licensing partner, Celladon Corporation, has reported today that Celladon’s first Phase II trial with MYDICAR®...

Targeted Genetics Reports Board Changes

Targeted Genetics Corporation (Pink Sheets:TGEN) (the “Company”) today announced that three of its outside board members, Dr.

Targeted Genetics Receives Milestone Payments

Targeted Genetics Corporation (Pink Sheets:TGEN) (the “Company”) today announced that it has completed the technology transfer portion of the September 2009 asset sale transaction executed between the Company and...

Targeted Genetics Sells Assets To Genzyme

Targeted Genetics sells assets to Genzyme for $7 million in cash

Targeted Genetics' Net Loss Widens

The drug company's revenue fell 30% in the fourth quarter.

Dendreon Posts Widened Loss, Explains Provenge Changes

The fourth-quarter results miss analysts estimates.

Wednesday's Small-Cap Winners & Losers

BladeLogic soars in its public debut.

These Gene-Drug Stocks Are Getting Hot

A Nobel Prize has stoked the fire in a hot biotech sector.

Targeted Genetics Reports Wider Loss

The gene therapy company's shares slumped after its quarter-over-quarter loss increased.